Valeritas appoints new CFO
This article was originally published in Scrip
Executive Summary
Valeritas, a US medical technology company developing and commercialising drug delivery solutions, has appointed James Dentzer as its new chief financial officer. Since 2006, he had served as chief financial officer of Amicus Therapeutics. Before that, Mr Dentzer was vice-president and corporate controller at Biogen Idec.